Poster: ABCL-040: Pirtobrutinib (LOXO-305), a Next-Generation, Highly Selective, Non-Covalent Bruton’s Tyrosine Kinase Inhibitor in Previously Treated Mantle Cell Lymphoma and Other Non-Hodgkin Lymphomas: Phase 1/2 BRUIN Study Results

2021 ◽  
Vol 21 ◽  
pp. S241
Author(s):  
Jonathon B. Cohen ◽  
Nirav N. Shah ◽  
Alvaro J. Alencar ◽  
James N. Gerson ◽  
Manish R. Patel ◽  
...  
Sign in / Sign up

Export Citation Format

Share Document